solution of 6-ohdahcl (3.0 μg/μl dissolved in saline containing 0.02% ascorbic acid (Millipore)
Millipore is a verified supplier 
90
Structured Review
Millipore
solution of 6-ohdahcl (3.0 μg/μl dissolved in saline containing 0.02% ascorbic acid
Solution Of 6 Ohdahcl (3.0 μg/μl Dissolved In Saline Containing 0.02% Ascorbic Acid, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/saline+solution+with+ascorbic+acid/6+ohda/pm30030752-45-9-24
Average 90 stars, based on 1 article reviews
Solution Of 6 Ohdahcl (3.0 μg/μl Dissolved In Saline Containing 0.02% Ascorbic Acid, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/saline+solution+with+ascorbic+acid/6+ohda/pm30030752-45-9-24
Average 90 stars, based on 1 article reviews
solution of 6-ohdahcl (3.0 μg/μl dissolved in saline containing 0.02% ascorbic acid - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Injection:Article Title: Synergistic effect of serotonin 1A and serotonin 1B/D receptor agonists in the treatment of L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned rats. Article Snippet: The rats were anesthetized with pentobarbital sodium (purchased from the Chinese domestic market) 50 mg/kg (IP), positioned in a stereotaxic frame and injected 6-OHDA HBr (Sigma Aldrich, 18 μg in 6 μl, dissolved in 0.9% NaCl with 0.02% ascorbic acid) into the medial forebrain bundle at the following coordinates relative to bregma and dural surface, in mm: tooth bar position − 3.3, AP = − 1.8, ML = − 2, DV = − 8.6 and at a rate of 0.5 μl/min, after which the injection cannula was left in place for an additional 2–3 min. Two weeks after surgery the animals were injected Article Title: Use of a composition comprising 7-hydroxymatairesinol Article Snippet: Animals received a unilateral injection of Article Title: Midbrain and Lateral Nucleus Accumbens Dopamine Depletion Affects Free-choice High-fat high-sugar Diet Preference in Male Rats. Article Snippet: Hamilton syringes with 33 gauge needles were used to deliver 2 mL of Article Title: Inhibition of Wnt/β-catenin signaling attenuates axonal degeneration in models of Parkinson's disease. Article Snippet: There are currently no treatments to delay or prevent Parkinson’s disease (PD), and protective treatments require early administration.. Targeting axonal degeneration in early PD could have an important clinical effect; however, the underlying molecular mechanisms controlling axonal degeneration in PD are not fully understood.. Here, we studied the role of Wnt/β-catenin signaling in axonal degeneration induced by 6-hydroxydopamine (6OHDA) or overexpression of alpha-synuclein (α-Syn) in vitro and in vivo. Article Title: The anti-dyskinetic effect of the clinic-ready mGluR 2 positive allosteric modulator AZD8529 in the 6-OHDA-lesioned rat. Article Snippet: l-3,4-dihydroxyphenylalanine (l-DOPA) remains the main treatment for motor symptoms of Parkinson’s disease (PD).. However, chronic use is associated with the development of complications such as l-DOPA-induced dyskinesia.. We previously demonstrated that LY-487,379, a highly selective metabotropic glutamate receptor 2 (mGluR2) positive allosteric modulator (PAM), reduces the severity of l-DOPA-induced abnormal involuntary movements (AIMs) in the 6-hydroxydopamine (6-OHDA)-lesioned rat model of PD, without interfering with the anti-parkinsonian action of l-DOPA. Article Title: Cell Fate Analysis of Embryonic Ventral Mesencephalic Grafts in the 6-OHDA Model of Parkinson's Disease Article Snippet: Under isoflurane anaesthesia (induction 3.5%, follow-up 1.5–2%), the animals received a unilateral injection of Article Title: Clonal Human Fetal Ventral Mesencephalic Dopaminergic Neuron Precursors for Cell Therapy Research Article Snippet: Rats received a Saline:Article Title: Synergistic effect of serotonin 1A and serotonin 1B/D receptor agonists in the treatment of L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned rats. Article Snippet: The rats were anesthetized with pentobarbital sodium (purchased from the Chinese domestic market) 50 mg/kg (IP), positioned in a stereotaxic frame and injected 6-OHDA HBr (Sigma Aldrich, 18 μg in 6 μl, dissolved in 0.9% NaCl with 0.02% ascorbic acid) into the medial forebrain bundle at the following coordinates relative to bregma and dural surface, in mm: tooth bar position − 3.3, AP = − 1.8, ML = − 2, DV = − 8.6 and at a rate of 0.5 μl/min, after which the injection cannula was left in place for an additional 2–3 min. Two weeks after surgery the animals were injected Article Title: Use of a composition comprising 7-hydroxymatairesinol Article Snippet: Animals received a unilateral injection of Article Title: Midbrain and Lateral Nucleus Accumbens Dopamine Depletion Affects Free-choice High-fat high-sugar Diet Preference in Male Rats. Article Snippet: Hamilton syringes with 33 gauge needles were used to deliver 2 mL of Article Title: Inhibition of Wnt/β-catenin signaling attenuates axonal degeneration in models of Parkinson's disease. Article Snippet: There are currently no treatments to delay or prevent Parkinson’s disease (PD), and protective treatments require early administration.. Targeting axonal degeneration in early PD could have an important clinical effect; however, the underlying molecular mechanisms controlling axonal degeneration in PD are not fully understood.. Here, we studied the role of Wnt/β-catenin signaling in axonal degeneration induced by 6-hydroxydopamine (6OHDA) or overexpression of alpha-synuclein (α-Syn) in vitro and in vivo. Article Title: The anti-dyskinetic effect of the clinic-ready mGluR 2 positive allosteric modulator AZD8529 in the 6-OHDA-lesioned rat. Article Snippet: l-3,4-dihydroxyphenylalanine (l-DOPA) remains the main treatment for motor symptoms of Parkinson’s disease (PD).. However, chronic use is associated with the development of complications such as l-DOPA-induced dyskinesia.. We previously demonstrated that LY-487,379, a highly selective metabotropic glutamate receptor 2 (mGluR2) positive allosteric modulator (PAM), reduces the severity of l-DOPA-induced abnormal involuntary movements (AIMs) in the 6-hydroxydopamine (6-OHDA)-lesioned rat model of PD, without interfering with the anti-parkinsonian action of l-DOPA. Article Title: Cell Fate Analysis of Embryonic Ventral Mesencephalic Grafts in the 6-OHDA Model of Parkinson's Disease Article Snippet: Under isoflurane anaesthesia (induction 3.5%, follow-up 1.5–2%), the animals received a unilateral injection of Article Title: Clonal Human Fetal Ventral Mesencephalic Dopaminergic Neuron Precursors for Cell Therapy Research Article Snippet: Rats received a |